0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Respiratory Infection Diagnostic Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-39D3651
Home | Market Reports | Health| Health Conditions
Global Respiratory Infection Diagnostic Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Respiratory Infection Diagnostic Market Research Report 2024

Code: QYRE-Auto-39D3651
Report
April 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Respiratory Infection Diagnostic Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Respiratory Infection Diagnostic Market

Respiratory Infection Diagnostic Market

The global Respiratory Infection Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Infection Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Infection Diagnostic.

Report Scope

The Respiratory Infection Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Infection Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Infection Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Respiratory Infection Diagnostic Market Report

Report Metric Details
Report Name Respiratory Infection Diagnostic Market
CAGR 5%
Segment by Type
  • Microbiology
  • PCR
  • NGS
  • Immunoassay
Segment by Application
  • Hospital Lab
  • Outpatient Lab
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ador Diagnostics, BD Diagnostics, Co-Diagnostics, Diagenode Diagnostics, GenePOC Diagnostics, Veradus Labs, Immunexpress, Janssen Diagnostics, Lumos Diagnostics, Oxford Nanopore, Prominex, Roche Molecular Diagnostics, SkylineDx, T2 Biosystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Respiratory Infection Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Respiratory Infection Diagnostic Market report?

Ans: The main players in the Respiratory Infection Diagnostic Market are Ador Diagnostics, BD Diagnostics, Co-Diagnostics, Diagenode Diagnostics, GenePOC Diagnostics, Veradus Labs, Immunexpress, Janssen Diagnostics, Lumos Diagnostics, Oxford Nanopore, Prominex, Roche Molecular Diagnostics, SkylineDx, T2 Biosystems

What are the Application segmentation covered in the Respiratory Infection Diagnostic Market report?

Ans: The Applications covered in the Respiratory Infection Diagnostic Market report are Hospital Lab, Outpatient Lab

What are the Type segmentation covered in the Respiratory Infection Diagnostic Market report?

Ans: The Types covered in the Respiratory Infection Diagnostic Market report are Microbiology, PCR, NGS, Immunoassay

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Infection Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Microbiology
1.2.3 PCR
1.2.4 NGS
1.2.5 Immunoassay
1.3 Market by Application
1.3.1 Global Respiratory Infection Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Lab
1.3.3 Outpatient Lab
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Infection Diagnostic Market Perspective (2019-2030)
2.2 Respiratory Infection Diagnostic Growth Trends by Region
2.2.1 Global Respiratory Infection Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Respiratory Infection Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Respiratory Infection Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Respiratory Infection Diagnostic Market Dynamics
2.3.1 Respiratory Infection Diagnostic Industry Trends
2.3.2 Respiratory Infection Diagnostic Market Drivers
2.3.3 Respiratory Infection Diagnostic Market Challenges
2.3.4 Respiratory Infection Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Infection Diagnostic Players by Revenue
3.1.1 Global Top Respiratory Infection Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Respiratory Infection Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Respiratory Infection Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Infection Diagnostic Revenue
3.4 Global Respiratory Infection Diagnostic Market Concentration Ratio
3.4.1 Global Respiratory Infection Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Infection Diagnostic Revenue in 2023
3.5 Respiratory Infection Diagnostic Key Players Head office and Area Served
3.6 Key Players Respiratory Infection Diagnostic Product Solution and Service
3.7 Date of Enter into Respiratory Infection Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Infection Diagnostic Breakdown Data by Type
4.1 Global Respiratory Infection Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Respiratory Infection Diagnostic Forecasted Market Size by Type (2025-2030)
5 Respiratory Infection Diagnostic Breakdown Data by Application
5.1 Global Respiratory Infection Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Respiratory Infection Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Respiratory Infection Diagnostic Market Size (2019-2030)
6.2 North America Respiratory Infection Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Respiratory Infection Diagnostic Market Size by Country (2019-2024)
6.4 North America Respiratory Infection Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Infection Diagnostic Market Size (2019-2030)
7.2 Europe Respiratory Infection Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Respiratory Infection Diagnostic Market Size by Country (2019-2024)
7.4 Europe Respiratory Infection Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Infection Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Respiratory Infection Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Infection Diagnostic Market Size (2019-2030)
9.2 Latin America Respiratory Infection Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Respiratory Infection Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Respiratory Infection Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Infection Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Respiratory Infection Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ador Diagnostics
11.1.1 Ador Diagnostics Company Detail
11.1.2 Ador Diagnostics Business Overview
11.1.3 Ador Diagnostics Respiratory Infection Diagnostic Introduction
11.1.4 Ador Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.1.5 Ador Diagnostics Recent Development
11.2 BD Diagnostics
11.2.1 BD Diagnostics Company Detail
11.2.2 BD Diagnostics Business Overview
11.2.3 BD Diagnostics Respiratory Infection Diagnostic Introduction
11.2.4 BD Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.2.5 BD Diagnostics Recent Development
11.3 Co-Diagnostics
11.3.1 Co-Diagnostics Company Detail
11.3.2 Co-Diagnostics Business Overview
11.3.3 Co-Diagnostics Respiratory Infection Diagnostic Introduction
11.3.4 Co-Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.3.5 Co-Diagnostics Recent Development
11.4 Diagenode Diagnostics
11.4.1 Diagenode Diagnostics Company Detail
11.4.2 Diagenode Diagnostics Business Overview
11.4.3 Diagenode Diagnostics Respiratory Infection Diagnostic Introduction
11.4.4 Diagenode Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.4.5 Diagenode Diagnostics Recent Development
11.5 GenePOC Diagnostics
11.5.1 GenePOC Diagnostics Company Detail
11.5.2 GenePOC Diagnostics Business Overview
11.5.3 GenePOC Diagnostics Respiratory Infection Diagnostic Introduction
11.5.4 GenePOC Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.5.5 GenePOC Diagnostics Recent Development
11.6 Veradus Labs
11.6.1 Veradus Labs Company Detail
11.6.2 Veradus Labs Business Overview
11.6.3 Veradus Labs Respiratory Infection Diagnostic Introduction
11.6.4 Veradus Labs Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.6.5 Veradus Labs Recent Development
11.7 Immunexpress
11.7.1 Immunexpress Company Detail
11.7.2 Immunexpress Business Overview
11.7.3 Immunexpress Respiratory Infection Diagnostic Introduction
11.7.4 Immunexpress Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.7.5 Immunexpress Recent Development
11.8 Janssen Diagnostics
11.8.1 Janssen Diagnostics Company Detail
11.8.2 Janssen Diagnostics Business Overview
11.8.3 Janssen Diagnostics Respiratory Infection Diagnostic Introduction
11.8.4 Janssen Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.8.5 Janssen Diagnostics Recent Development
11.9 Lumos Diagnostics
11.9.1 Lumos Diagnostics Company Detail
11.9.2 Lumos Diagnostics Business Overview
11.9.3 Lumos Diagnostics Respiratory Infection Diagnostic Introduction
11.9.4 Lumos Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.9.5 Lumos Diagnostics Recent Development
11.10 Oxford Nanopore
11.10.1 Oxford Nanopore Company Detail
11.10.2 Oxford Nanopore Business Overview
11.10.3 Oxford Nanopore Respiratory Infection Diagnostic Introduction
11.10.4 Oxford Nanopore Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.10.5 Oxford Nanopore Recent Development
11.11 Prominex
11.11.1 Prominex Company Detail
11.11.2 Prominex Business Overview
11.11.3 Prominex Respiratory Infection Diagnostic Introduction
11.11.4 Prominex Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.11.5 Prominex Recent Development
11.12 Roche Molecular Diagnostics
11.12.1 Roche Molecular Diagnostics Company Detail
11.12.2 Roche Molecular Diagnostics Business Overview
11.12.3 Roche Molecular Diagnostics Respiratory Infection Diagnostic Introduction
11.12.4 Roche Molecular Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.12.5 Roche Molecular Diagnostics Recent Development
11.13 SkylineDx
11.13.1 SkylineDx Company Detail
11.13.2 SkylineDx Business Overview
11.13.3 SkylineDx Respiratory Infection Diagnostic Introduction
11.13.4 SkylineDx Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.13.5 SkylineDx Recent Development
11.14 T2 Biosystems
11.14.1 T2 Biosystems Company Detail
11.14.2 T2 Biosystems Business Overview
11.14.3 T2 Biosystems Respiratory Infection Diagnostic Introduction
11.14.4 T2 Biosystems Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.14.5 T2 Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Respiratory Infection Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Microbiology
    Table 3. Key Players of PCR
    Table 4. Key Players of NGS
    Table 5. Key Players of Immunoassay
    Table 6. Global Respiratory Infection Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Respiratory Infection Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Respiratory Infection Diagnostic Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Respiratory Infection Diagnostic Market Share by Region (2019-2024)
    Table 10. Global Respiratory Infection Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Respiratory Infection Diagnostic Market Share by Region (2025-2030)
    Table 12. Respiratory Infection Diagnostic Market Trends
    Table 13. Respiratory Infection Diagnostic Market Drivers
    Table 14. Respiratory Infection Diagnostic Market Challenges
    Table 15. Respiratory Infection Diagnostic Market Restraints
    Table 16. Global Respiratory Infection Diagnostic Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Respiratory Infection Diagnostic Market Share by Players (2019-2024)
    Table 18. Global Top Respiratory Infection Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infection Diagnostic as of 2023)
    Table 19. Ranking of Global Top Respiratory Infection Diagnostic Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Respiratory Infection Diagnostic Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Respiratory Infection Diagnostic Product Solution and Service
    Table 23. Date of Enter into Respiratory Infection Diagnostic Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Respiratory Infection Diagnostic Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Respiratory Infection Diagnostic Revenue Market Share by Type (2019-2024)
    Table 27. Global Respiratory Infection Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Respiratory Infection Diagnostic Revenue Market Share by Type (2025-2030)
    Table 29. Global Respiratory Infection Diagnostic Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Respiratory Infection Diagnostic Revenue Market Share by Application (2019-2024)
    Table 31. Global Respiratory Infection Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Respiratory Infection Diagnostic Revenue Market Share by Application (2025-2030)
    Table 33. North America Respiratory Infection Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Respiratory Infection Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Respiratory Infection Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Respiratory Infection Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Respiratory Infection Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Respiratory Infection Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Respiratory Infection Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Respiratory Infection Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Respiratory Infection Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Respiratory Infection Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Respiratory Infection Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Ador Diagnostics Company Detail
    Table 49. Ador Diagnostics Business Overview
    Table 50. Ador Diagnostics Respiratory Infection Diagnostic Product
    Table 51. Ador Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 52. Ador Diagnostics Recent Development
    Table 53. BD Diagnostics Company Detail
    Table 54. BD Diagnostics Business Overview
    Table 55. BD Diagnostics Respiratory Infection Diagnostic Product
    Table 56. BD Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 57. BD Diagnostics Recent Development
    Table 58. Co-Diagnostics Company Detail
    Table 59. Co-Diagnostics Business Overview
    Table 60. Co-Diagnostics Respiratory Infection Diagnostic Product
    Table 61. Co-Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 62. Co-Diagnostics Recent Development
    Table 63. Diagenode Diagnostics Company Detail
    Table 64. Diagenode Diagnostics Business Overview
    Table 65. Diagenode Diagnostics Respiratory Infection Diagnostic Product
    Table 66. Diagenode Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 67. Diagenode Diagnostics Recent Development
    Table 68. GenePOC Diagnostics Company Detail
    Table 69. GenePOC Diagnostics Business Overview
    Table 70. GenePOC Diagnostics Respiratory Infection Diagnostic Product
    Table 71. GenePOC Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 72. GenePOC Diagnostics Recent Development
    Table 73. Veradus Labs Company Detail
    Table 74. Veradus Labs Business Overview
    Table 75. Veradus Labs Respiratory Infection Diagnostic Product
    Table 76. Veradus Labs Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 77. Veradus Labs Recent Development
    Table 78. Immunexpress Company Detail
    Table 79. Immunexpress Business Overview
    Table 80. Immunexpress Respiratory Infection Diagnostic Product
    Table 81. Immunexpress Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 82. Immunexpress Recent Development
    Table 83. Janssen Diagnostics Company Detail
    Table 84. Janssen Diagnostics Business Overview
    Table 85. Janssen Diagnostics Respiratory Infection Diagnostic Product
    Table 86. Janssen Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 87. Janssen Diagnostics Recent Development
    Table 88. Lumos Diagnostics Company Detail
    Table 89. Lumos Diagnostics Business Overview
    Table 90. Lumos Diagnostics Respiratory Infection Diagnostic Product
    Table 91. Lumos Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 92. Lumos Diagnostics Recent Development
    Table 93. Oxford Nanopore Company Detail
    Table 94. Oxford Nanopore Business Overview
    Table 95. Oxford Nanopore Respiratory Infection Diagnostic Product
    Table 96. Oxford Nanopore Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 97. Oxford Nanopore Recent Development
    Table 98. Prominex Company Detail
    Table 99. Prominex Business Overview
    Table 100. Prominex Respiratory Infection Diagnostic Product
    Table 101. Prominex Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 102. Prominex Recent Development
    Table 103. Roche Molecular Diagnostics Company Detail
    Table 104. Roche Molecular Diagnostics Business Overview
    Table 105. Roche Molecular Diagnostics Respiratory Infection Diagnostic Product
    Table 106. Roche Molecular Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 107. Roche Molecular Diagnostics Recent Development
    Table 108. SkylineDx Company Detail
    Table 109. SkylineDx Business Overview
    Table 110. SkylineDx Respiratory Infection Diagnostic Product
    Table 111. SkylineDx Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 112. SkylineDx Recent Development
    Table 113. T2 Biosystems Company Detail
    Table 114. T2 Biosystems Business Overview
    Table 115. T2 Biosystems Respiratory Infection Diagnostic Product
    Table 116. T2 Biosystems Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
    Table 117. T2 Biosystems Recent Development
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Respiratory Infection Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Respiratory Infection Diagnostic Market Share by Type: 2023 VS 2030
    Figure 3. Microbiology Features
    Figure 4. PCR Features
    Figure 5. NGS Features
    Figure 6. Immunoassay Features
    Figure 7. Global Respiratory Infection Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Respiratory Infection Diagnostic Market Share by Application: 2023 VS 2030
    Figure 9. Hospital Lab Case Studies
    Figure 10. Outpatient Lab Case Studies
    Figure 11. Respiratory Infection Diagnostic Report Years Considered
    Figure 12. Global Respiratory Infection Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Respiratory Infection Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Respiratory Infection Diagnostic Market Share by Region: 2023 VS 2030
    Figure 15. Global Respiratory Infection Diagnostic Market Share by Players in 2023
    Figure 16. Global Top Respiratory Infection Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infection Diagnostic as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Respiratory Infection Diagnostic Revenue in 2023
    Figure 18. North America Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Respiratory Infection Diagnostic Market Share by Country (2019-2030)
    Figure 20. United States Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Respiratory Infection Diagnostic Market Share by Country (2019-2030)
    Figure 24. Germany Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Respiratory Infection Diagnostic Market Share by Region (2019-2030)
    Figure 32. China Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Respiratory Infection Diagnostic Market Share by Country (2019-2030)
    Figure 40. Mexico Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Respiratory Infection Diagnostic Market Share by Country (2019-2030)
    Figure 44. Turkey Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Ador Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 47. BD Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 48. Co-Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 49. Diagenode Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 50. GenePOC Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 51. Veradus Labs Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 52. Immunexpress Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 53. Janssen Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 54. Lumos Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 55. Oxford Nanopore Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 56. Prominex Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 57. Roche Molecular Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 58. SkylineDx Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 59. T2 Biosystems Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS